LDL cholesteryl oleate: a biomarker for atherosclerosis?
Spector
Arthur A
AA
Haynes
William G
WG
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology / Q000627:therapeutic use; D050197:Atherosclerosis / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism*; D015415:Biomarkers / Q000097:blood; D002788:Cholesterol Esters / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D004041:Dietary Fats / Q000009:adverse effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000378:metabolism; D002785:Sterol O-Acyltransferase / Q000037:antagonists & inhibitors / Q000378:metabolism; D000097587:Sterol O-Acyltransferase 2
D000924:Anticholesteremic Agents; D015415:Biomarkers; D002788:Cholesterol Esters; D008078:Cholesterol, LDL; D004041:Dietary Fats; D004791:Enzyme Inhibitors; D002785:Sterol O-Acyltransferase; D000097587:Sterol O-Acyltransferase 2; C014409:cholesteryl oleate